Fleseriu, M., Petersenn, S., Biller, B. M. K., Kadioglu, P., De Block, C., T'Sjoen, G., . . . Newell‐Price, J. (2019). Long‐term efficacy and safety of once‐monthly pasireotide in Cushing's disease: A Phase III extension study. Clin Endocrinol (Oxf).
Dyfyniad Arddull ChicagoFleseriu, Maria, et al. "Long‐term Efficacy and Safety of Once‐monthly Pasireotide in Cushing's Disease: A Phase III Extension Study." Clin Endocrinol (Oxf) 2019.
Dyfyniad MLAFleseriu, Maria, et al. "Long‐term Efficacy and Safety of Once‐monthly Pasireotide in Cushing's Disease: A Phase III Extension Study." Clin Endocrinol (Oxf) 2019.
Rhybudd: Mae'n bosib nad yw'r dyfyniadau hyn bob amser yn 100% cywir.